4891 TMS
- 239
- -1-0.42%
TMS News
TMS: Notice regarding the development of TMS-008
TMS: Notice Concerning SMTP Compound Related Patents (Japan)
TMS: Notice of the 20th Annual General Meeting of Shareholders
TMS: Notice of Convocation of the 20th Annual General Meeting of Shareholders (matters not described in issued documents)
TMS: Notice of Convocation of the 20th Annual General Meeting of Shareholders
TMS: Announcement of the release of transcribed articles and videos of the financial results briefing for the fiscal year ending 2024/2
TMS: Presentation Material for the Fiscal Year Ended February 29,2024
TMS: Financial results presentation materials for the fiscal year ending 2024/2
TMS: Non-consolidated Financial Results for the Fiscal Year Ended February 29, 2024 [Japanese GAAP]
TMS: Summary of financial results for the fiscal year ending February 2024 [Japanese GAAP] (unconsolidated)
TMS: Notice regarding differences between individual results and the previous year's results
Tims: Change Report (Stock Certificates Subject to Special Cases, etc.)
Tims: Change Report (Stock Certificates Subject to Special Cases, etc.)
Timms: Announcement of publication of a transcript of the “IR Seminar for Individual Investors” hosted by Logme Finance
Tims: Notice of submission of a clinical trial plan notification form for the domestic phase 1 clinical trial of TMS-008
Tims: TMS submits clinical trial plan notification for TMS-008 phase I clinical trial in Japan
Tims: Notice of conclusion of license agreement relating to JX09
TMS: JIXING Announced the First Subject Dosing of JX09 Phase I Clinical Trial
TMS: JIXING completes administration of the first phase 1 clinical trial of JX09
TMS: Announcement of speakers at the “IR Seminar for Individual Investors” hosted by Logme Finance
Analysis
Price Target
No Data
